228 related articles for article (PubMed ID: 32920420)
1. Role of hysteroscopy and ultrasound in early identification of post-molar gestational trophoblastic neoplasia.
Subbaiah M; Raj A; Durairaj J; Keepanasseril A
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():33-37. PubMed ID: 32920420
[TBL] [Abstract][Full Text] [Related]
2. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
3. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of B-human chorionic gonadotropin for progression of molar pregnancy to persistent gestational trophoblastic neoplasm.
Yarandi F; Mohseni M; Alikhasi M; Ramhormozian S; Shirali E
Minerva Obstet Gynecol; 2023 Jun; 75(3):205-212. PubMed ID: 34498836
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia.
Rakprasit C; Ruengkhachorn I; Therasakvichya S; Inthasorn P; Achariyapota V; Kuljarasnont S; Khemworapong K; Jareemit N
Arch Gynecol Obstet; 2023 Apr; 307(4):1145-1154. PubMed ID: 36116082
[TBL] [Abstract][Full Text] [Related]
6. Sonographic characteristics of post-molar gestational trophoblastic neoplasia at diagnosis and during follow-up, and relationship with methotrexate resistance.
Epstein E; Joneborg U
Ultrasound Obstet Gynecol; 2020 Nov; 56(5):759-765. PubMed ID: 31909527
[TBL] [Abstract][Full Text] [Related]
7. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia.
Garavaglia E; Gentile C; Cavoretto P; Spagnolo D; Valsecchi L; Mangili G
Am J Obstet Gynecol; 2009 Apr; 200(4):417.e1-5. PubMed ID: 19200936
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
10. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
11. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
13. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
15. Assessment of current follow-up for complete molar pregnancies: A single centre review.
Mylvaganam G; Allanson E; Allanson B; Philp S; Pather S; Farrell R; Carter J; Tejada-Berges T
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):213-216. PubMed ID: 33034043
[TBL] [Abstract][Full Text] [Related]
16. Video Hysteroscopy in the Diagnosis of Molar Pregnancy in two Challenging Situations: Complete Mole with Normal hCG and Partial Mole with Early Gestational Age.
Braga A; Padrón L; Balen JL; Elias KM; Horowitz NS; Berkowitz RS
J Minim Invasive Gynecol; 2021 Aug; 28(8):1448-1449. PubMed ID: 33556583
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
18. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
19. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
20. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
